Gastroesophageal reflux disease (GERD) is estimated to affect nearly 20% of Americans. Recent advances in our understanding of GERD have changed clinical practice. Therefore, in February 2022, the American College of Gastroenterology (ACG) released an updated set of guidelines for the diagnosis and management of GERD. Research from Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health, helped shape these new practice guidelines.
An estimated 3 million individuals in the U.S. live with a condition called atrial fibrillation, or AFib, with some estimates projecting that number being closer to 6 million when taking unknown and undiagnosed cases into account.
Baylor Scott & White Research Institute (BSWRI) is well known for its diverse research portfolio. The program actively maintains nearly 2,000 active and enrolling projects across more than 50 medical specialties each year, including initiatives supported by its translational research program. The program is focused on driving innovation by working with clinical teams across the Baylor Scott & White Health System to develop new medicines and diagnostic tests. The translational research team’s approach to discovery of “bench-to-bedside- and- back-to-bench” allows BSWRI to continue to be a major contributor to advancements in medical science.
Annual low-dose CT (LDCT) scans for people at high risk for lung cancer have proved to reduce the chance of death from the disease by 20 percent. However, only about 5 percent of eligible people are being screened.
At the point a patient with advanced lung disease is considered for transplant, he or she is severely ill. While all transplants are challenging, patients who undergo lung transplant can face a particularly rough road. To gain a more in-depth understanding of the patient under consideration, Baylor University Medical Center at Dallas (Baylor Dallas), part of Baylor Scott & White Health, has embedded supportive palliative care into the lung transplant program.
The heart transplant team from Baylor University Medical Center at Dallas (Baylor Dallas), part of Baylor Scott & White Health, played a prominent role at the American Transplant Congress (ATC) meeting, held June 3 – 7, 2023 in San Diego, Calif. A joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation (AST), the forum exchanges new clinical information on tissue and solid organ transplantation and provides education on cutting-edge advances and research. The conference brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists and allied health professionals.
Baylor Scott & White Health played a leading role at the 43rd Annual Meeting & Scientific Sessions of The International Society for Heart and Lung Transplantation (ISHLT), held April 19-22, 2023, in Denver, Colorado. More than 3,600 members from around the world gathered to exchange ideas and collaborate on the latest science.
To provide advanced heart failure treatment to patients in north Louisiana, Baylor Scott & White Health has established an outreach clinic in Shreveport. Since October 2022, Amarinder Bindra, MD, an advanced heart failure and transplant cardiologist on the medical staff at Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health, sees six to eight new patients at each weekly visit.
